Compare Humana Inc (HUM) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs ResMed Inc. — how do they compare? Humana Inc trades at $404.82 (market cap $47.81B), while ResMed Inc. trades at $196 (market cap $28.81B). The key difference: Humana Inc is the larger of the two by market cap, and ResMed Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| HUM | RMD | |
|---|---|---|
Market Cap | $47.81B | $28.81B |
Sector | Health | Health |
52-Week High | $409.42 | $293.73 |
52-Week Low | $163.67 | $182.82 |
Enterprise Value | $56.85B | $27.99B |
Dividend Yield | 0.89% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
